208 related articles for article (PubMed ID: 26384276)
1. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.
Kerns SL; Kundu S; Oh JH; Singhal SK; Janelsins M; Travis LB; Deasy JO; Janssens AC; Ostrer H; Parliament M; Usmani N; Rosenstein BS
Semin Radiat Oncol; 2015 Oct; 25(4):281-91. PubMed ID: 26384276
[TBL] [Abstract][Full Text] [Related]
2. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
3. Prediction of normal tissue toxicity as part of the individualized treatment with radiotherapy in oncology patients.
Henríquez-Hernández LA; Bordón E; Pinar B; Lloret M; Rodríguez-Gallego C; Lara PC
Surg Oncol; 2012 Sep; 21(3):201-6. PubMed ID: 22209348
[TBL] [Abstract][Full Text] [Related]
4. Radiogenomics: the search for genetic predictors of radiotherapy response.
Kerns SL; West CM; Andreassen CN; Barnett GC; Bentzen SM; Burnet NG; Dekker A; De Ruysscher D; Dunning A; Parliament M; Talbot C; Vega A; Rosenstein BS
Future Oncol; 2014 Dec; 10(15):2391-406. PubMed ID: 25525847
[TBL] [Abstract][Full Text] [Related]
5. Radiogenomics - current status, challenges and future directions.
Andreassen CN; Schack LM; Laursen LV; Alsner J
Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomics: the promise of personalized treatment in radiation oncology?
Proud C
Clin J Oncol Nurs; 2014 Apr; 18(2):185-9. PubMed ID: 24675253
[TBL] [Abstract][Full Text] [Related]
7. Predictive markers for normal tissue reactions: fantasy or reality?
Fernet M; Hall J
Cancer Radiother; 2008 Nov; 12(6-7):614-8. PubMed ID: 18752979
[TBL] [Abstract][Full Text] [Related]
8. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
Bentzen SM
Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
Peters LJ
Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
[TBL] [Abstract][Full Text] [Related]
10. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
11. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
Kerns SL; Ostrer H; Rosenstein BS
Cancer Discov; 2014 Feb; 4(2):155-65. PubMed ID: 24441285
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
13. Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon.
Kerns SL; Hall WA; Marples B; West CML
Semin Radiat Oncol; 2023 Jul; 33(3):307-316. PubMed ID: 37331785
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of the pathological changes induced by radiotherapy in normal tissues.
Rezvani M
J Pharm Pharmacol; 2008 Aug; 60(8):1037-48. PubMed ID: 18644196
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Bourgier C; Levy A; Vozenin MC; Deutsch E
Cancer Metastasis Rev; 2012 Dec; 31(3-4):699-712. PubMed ID: 22706781
[TBL] [Abstract][Full Text] [Related]
16. T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M; Lapierre A; Bourgier C; Pèlegrin A; Özsahin M; Azria D
Expert Rev Mol Diagn; 2017 Feb; 17(2):119-127. PubMed ID: 27936985
[TBL] [Abstract][Full Text] [Related]
17. Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates.
Vinogradskiy Y; Tucker SL; Bluett JB; Wages CA; Liao Z; Martel MK
J Thorac Oncol; 2012 Nov; 7(11):1676-82. PubMed ID: 23059778
[TBL] [Abstract][Full Text] [Related]
18. Genetic markers for prediction of normal tissue toxicity after radiotherapy.
Alsner J; Andreassen CN; Overgaard J
Semin Radiat Oncol; 2008 Apr; 18(2):126-35. PubMed ID: 18314067
[TBL] [Abstract][Full Text] [Related]
19. Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy.
Rosenstein BS
Pharmacogenomics; 2011 Feb; 12(2):267-75. PubMed ID: 21332318
[TBL] [Abstract][Full Text] [Related]
20. Effects of radiation on normal tissue: consequences and mechanisms.
Stone HB; Coleman CN; Anscher MS; McBride WH
Lancet Oncol; 2003 Sep; 4(9):529-36. PubMed ID: 12965273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
